Butzbach, Germany

Friedrich Grimminger

This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Nycomed Gmbh, Fresenius Ag. Active years: 1996-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Friedrich Grimminger. Retrieved from https://idiyas.com/inventor/friedrich-grimminger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 180(Granted Patents)


Company Filing History:


Years Active: 1996-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Friedrich Grimminger: A Pioneer in PDE5 Inhibitors

Introduction

Friedrich Grimminger is a prominent inventor based in Butzbach, Germany. Known for his significant contributions to the field of medicine, he holds three patents. His work primarily revolves around the innovative use of PDE5 inhibitors, which have had a considerable impact on medical treatments.

Latest Patents

Grimminger's latest patents focus on the use of PDE5 inhibitors in medicine. This invention has the potential to revolutionize various treatment modalities due to the critical role these inhibitors play in managing specific health conditions. The applicability of his patents showcases the ongoing advancements in pharmacological therapies.

Career Highlights

Throughout his career, Grimminger has been associated with notable companies, including Nycomed GmbH and Fresenius AG. His experience in these organizations has allowed him to develop and refine his inventions and contribute to the broader field of medical science.

Collaborations

Grimminger has worked alongside esteemed colleagues, including Torsten Dunkern and Christian Schudt. These collaborations have enriched his research and development efforts, paving the way for innovative breakthroughs in the application of PDE5 inhibitors.

Conclusion

Friedrich Grimminger's work exemplifies the spirit of innovation within the medical field. With his three patents and collaborations with reputable companies and experts, he continues to advance the understanding and use of PDE5 inhibitors in medicine, significantly impacting patient care and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…